Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) By Investing.com
    News

    LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) By Investing.com

    userBy userJanuary 2, 2025No Comments2 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email



    ORLANDO, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) — LENSAR, Inc.  (Nasdaq: LNSR) (LENSAR or the Company) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees stock options to purchase an aggregate of 1,650 shares of the Company’s common stock. The options were granted as of  January 2, 2025, as inducements material to each employee entering into employment with the Company. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

    The options have an exercise price of  $8.69  per share, which is equal to the closing price of the Company’s common stock on the grant date. The options vest as to 25% of the total amount of the award on the one-year anniversary of the grant date and in thirty-six substantially equal monthly installments thereafter, subject to the new employee’s continued service with the company. Each stock option has a 10-year term. The options are subject to the terms and conditions of LENSAR’s 2024 Employment Inducement Incentive Award Plan and a stock option agreement covering the grant.

    About LENSAR

    LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. LENSAR has developed its ALLY  Robotic Cataract Laser System™ as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating AI into proprietary imaging and software. ALLY is designed to transform premium cataract surgery by utilizing LENSAR’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reducing overhead. ALLY includes LENSAR’s proprietary Streamline ®  software technology, which is designed to guide surgeons to achieve better outcomes.

    Contacts:   Lee Roth / Cameron Radinovic
    Thomas R. Staab, II, CFO   Burns McClellan for LENSAR
    ir.contact@lensar.com   lroth@burnsmc.com / cradinovic@burnsmc.com

    Source: LENSAR, Inc.





    Source link

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleSony Ventures Says These Trends Are Shaping Climate Tech Investment
    Next Article Meta’s chief legal officer Jennifer Newstead sells $535,542 worth of stock By Investing.com
    user
    • Website

    Related Posts

    Public or private? Funding debate splits reeling aid sector

    July 6, 2025

    £10k to invest? Here’s a hot dividend share that could deliver a £2,653 passive income over just 3 years

    July 6, 2025

    Global Uncertainties Affecting Private Capex; Industries Will Cheer US-India Deal, Rajiv Memani Says

    July 6, 2025
    Add A Comment

    Leave a ReplyCancel reply

    © 2025 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d